We’re committed to advancing all aspects of life with hemophilia, starting with patient care. We strive to provide Treatment for All who need it, including underserved communities around the globe.
Living with a serious illness can come with many challenges. Getting Genentech medicines shouldn’t be one of them
Did You Know?
The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or have financial concerns.
Across the US, Genentech works to answer questions about insurance coverage and assistance. Your health insurance plan and the cost of your medicine might keep you from getting your medicine. We may be able to help. Genentech Access Solutions is a program that helps people who are taking a Genentech medicine.
World Federation of Hemophilia
In 2019, Genentech and our parent company Roche joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program with a mission to provide prophylactic treatment to people with hemophilia A in developing countries.
Together, we are committed to providing treatment to 1,000 people over the course of 5 years, focusing on high-need patients. WFH identifies those countries that have a great need for access to care and also have healthcare systems in place to effectively use donated treatment.
Former WFH president Mark Skinner gives his vision statement for Treatment for All, explaining the goals it seeks to meet each year, as well as how it can meet the needs of people with hemophilia, beyond medicine.
Save One Life
Save One Life is an organization that works to impact the global bleeding disorders community, one life at a time.
During a visit to Nepal, Chris Bombardier, executive director of Save One Life, saw firsthand what the challenges of living with a bleeding disorder in a developing country can mean for those seeking support.
The Micro-Enterprise Grant
Laurie Kelley, the founder of Save One Life, started the Micro-Enterprise Grant program in 2014 after seeing and talking to parents and families about their challenges.
The grant program works with 50+ global program partners in developing countries to provide resources to individuals or families with bleeding disorders to assist their small business.
Grants Through the Years
Grants can be used for anything from farming to technology services. “Something as small as selling cow’s milk could impact one’s life so tremendously in these developing countries,” Bombardier says.
Save One Life plans to sponsor more grants as Genentech and Roche continue to get involved. Says Bombardier, “The commitment from Genentech and Roche has been one of the most exciting things to happen to the program in a while. This stability allows us to offer more.”
Our Hemophilia Clinical Education Managers (CEMs) serve all 50 states and US territories. They have years of nursing/clinical experience with a host of helpful resources—and they can provide opportunities to connect with Genentech and the community at chapter events, conferences, and educational programs.
Clinical Education Managers do not provide medical advice.
Please enter your ZIP Code below.
Hear how our team of Hemophilia Community Clinical Education Managers provides support, in their own words.
Monitoring the safety of a drug during clinical trials AND after is called pharmacovigilance. “Pharma” comes from the Greek word “pharmakeia”—for drugs, medicines, or remedies. “Vigilance” is from the Latin “vigilantia,” meaning wakefulness, watchfulness, or attention.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.